| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |